Can the Lung Cancer Pie Be Divided into Angiogenic Slices?

od Cascone, Tina, Heymach, John V.
Wydane w Clin Cancer Res (2015)

Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer

od Sepesi, Boris, Cascone, Tina, Chun, Stephen G., Altan, Mehmet, Le, Xiuning
Wydane w Surg Oncol Clin N Am (2020)

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer

od Pradhan, Monika, Chocry, Mathieu, Gibbons, Don L., Sepesi, Boris, Cascone, Tina
Wydane w Transl Lung Cancer Res (2021)

Targeted Therapies for Lung Cancer: Clinical Experience and Novel Agents

od Larsen, Jill E., Cascone, Tina, Gerber, David E., Heymach, John V., Minna, John D.
Wydane 2011

Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy

od Bhardwaj, Vikas, Cascone, Tina, Cortez, M Angelica, Amini, Arya, Evans, Jaden, Komaki, Ritusko U, Heymach, John V, Welsh, James W
Wydane 2013

Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer

od Byers, Lauren Averett, Sen, Banibrata, Saigal, Babita, Diao, Lixia, Wang, Jing, Nanjundan, Meera, Cascone, Tina, Mills, Gordon B., Heymach, John V., Johnson, Faye M.
Wydane 2009

Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy

od Mehran, Reza, Nilsson, Monique, Khajavi, Mehrdad, Du, Zhiqiang, Cascone, Tina, Wu, Hua Kang, Cortes, Andrea, Xu, Li, Zurita, Amado, Schier, Robert, Riedel, Bernhard, El-Zein, Randa, Heymach, John V.
Wydane 2014

Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged Non-Small Cell Lung Cancer with brain metastases

od Subbiah, Vivek, Berry, Jenny, Roxas, Michael, Guha-Thakurta, Nandita, Subbiah, Ishwaria Mohan, Ali, Siraj M., McMahon, Caitlin, Miller, Vincent, Cascone, Tina, Pai, Shobha, Tang, Zhenya, Heymach, John V.
Wydane w Lung Cancer (2015)

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer

od Cascone, Tina, Gold, Kathryn A., Swisher, Stephen G., Liu, Diane D., Fossella, Frank V., Sepesi, Boris, Pataer, Apar, Weissferdt, Annikka, Kalhor, Neda, Vaporciyan, Ara, Hofstetter, Wayne L., Wistuba, Ignacio I., Heymach, John V., Kim, Edward S., William, William N.
Wydane w Ann Thorac Surg (2017)

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma

od Cascone, Tina, Herynk, Matthew H., Xu, Li, Du, Zhiqiang, Kadara, Humam, Nilsson, Monique B., Oborn, Carol J., Park, Yun-Yong, Erez, Baruch, Jacoby, Jörg J., Lee, Ju-Seog, Lin, Heather Y., Ciardiello, Fortunato, Herbst, Roy S., Langley, Robert R., Heymach, John V.
Wydane 2011

Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

od Weissferdt, Annikka, Pataer, Apar, Vaporciyan, Ara A., Correa, Arlene M., Sepesi, Boris, Moran, Cesar A., Wistuba, Ignacio I., Roth, Jack A., Shewale, Jitesh Baban, Heymach, John V., Kalhor, Neda, Cascone, Tina, Hofstetter, Wayne L., Lee, J. Jack, Swisher, Stephen G.
Wydane w Clin Lung Cancer (2020)

Lymphovascular Invasion Is Associated with Mutational Burden and PD-L1 in Resected Lung Cancer

od Mitchell, Kyle G., Negrao, Marcelo V., Parra, Edwin R., Li, Jun, Zhang, Jianhua, Dejima, Hitoshi, Vaporciyan, Ara A., Swisher, Stephen G., Weissferdt, Annikka, Antonoff, Mara B., Cascone, Tina, Roarty, Emily, Wistuba, Ignacio I., Heymach, John V., Gibbons, Don L., Zhang, Jianjun, Sepesi, Boris
Wydane w Ann Thorac Surg (2019)

KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling

od Wagner, Klaus W., Alam, Hunain, Dhar, Shilpa S., Giri, Uma, Li, Na, Wei, Yongkun, Giri, Dipak, Cascone, Tina, Kim, Jae-Hwan, Ye, Yuanqing, Multani, Asha S., Chan, Chia-Hsin, Erez, Baruch, Saigal, Babita, Chung, Jimyung, Lin, Hui-Kuan, Wu, Xifeng, Hung, Mien-Chie, Heymach, John V., Lee, Min Gyu
Wydane 2013

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

od Naumov, George N., Nilsson, Monique B., Cascone, Tina, Briggs, Alexandra, Straume, Oddbjorn, Akslen, Lars A., Lifshits, Eugene, Byers, Lauren Averett, Xu, Li, Wu, Hua-kang, Jänne, Pasi, Kobayashi, Susumu, Halmos, Balazs, Tenen, Daniel, Tang, Xi M., Engelman, Jeffrey, Yeap, Beow, Folkman, Judah, Johnson, Bruce E., Heymach, John V.
Wydane 2009

A β3 integrin-KRAS-RalB complex drives tumor stemness and resistance to EGFR inhibition

od Seguin, Laetitia, Kato, Shumei, Franovic, Aleksandra, Camargo, M. Fernanda, Lesperance, Jacqueline, Elliott, Kathryn C., Yebra, Mayra, Mielgo, Ainhoa, Lowy, Andrew M., Husain, Hatim, Cascone, Tina, Diao, Lixia, Wang, Jing, Wistuba, Ignacio I., Heymach, John V., Lippman, Scott M., Desgrosellier, Jay S., Anand, Sudarshan, Weis, Sara M., Cheresh, David A.
Wydane 2014

Altered regulation of HIF-1α in naïve- and drug-resistant EGFR mutant NSCLC: implications for a VEGF-dependent phenotype

od Nilsson, Monique B., Robichaux, Jacqulyne, Herynk, Matthew H., Cascone, Tina, Le, Xuining, Elamin, Yasir, Patel, Sonia, Zhang, Fahao, Xu, Li, Hu, Limei, Diao, Lixia, Shen, Li, He, Junqin, Yu, Xiaoxing, Nikolinakos, Petros, Saintigny, Pierre, Fang, Bingliang, Girard, Luc, Wang, Jing, Minna, John D., Wistuba, Ignacio I., Heymach, John V.
Wydane w J Thorac Oncol (2020)

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

od Parra, Edwin R., Villalobos, Pamela, Behrens, Carmen, Jiang, Mei, Pataer, Apar, Swisher, Stephen G., William, William N., Zhang, Jiexin, Lee, Jack, Cascone, Tina, Heymach, John V., Forget, Marie-Andrée, Haymaker, Cara, Bernatchez, Chantale, Kalhor, Neda, Weissferdt, Annikka, Moran, Cesar, Zhang, Jianjun, Vaporciyan, Ara, Gibbons, Don L., Sepesi, Boris, Wistuba, Ignacio I.
Wydane w J Immunother Cancer (2018)

Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care

od Simon, George, DiNardo, Courtney D., Takahashi, Koichi, Cascone, Tina, Powers, Cynthia, Stevens, Rick, Allen, Joshua, Antonoff, Mara B., Gomez, Daniel, Keane, Pat, Suarez Saiz, Fernando, Nguyen, Quynh, Roarty, Emily, Pierce, Sherry, Zhang, Jianjun, Hardeman Barnhill, Emily, Lakhani, Kate, Shaw, Kenna, Smith, Brett, Swisher, Stephen, High, Rob, Futreal, P. Andrew, Heymach, John, Chin, Lynda
Wydane w Oncologist (2018)

Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively i...

od Mitchell, Kyle G, Diao, Lixia, Karpinets, Tatiana, Negrao, Marcelo V, Tran, Hai T, Parra, Edwin R, Corsini, Erin M, Reuben, Alexandre, Federico, Lorenzo, Bernatchez, Chantale, Dejima, Hitoshi, Francisco-Cruz, Alejandro, Wang, Jing, Antonoff, Mara B, Vaporciyan, Ara A, Swisher, Stephen G, Cascone, Tina, Wistuba, Ignacio I, Heymach, John V, Gibbons, Don L, Zhang, Jianjun, Haymaker, Cara L, Sepesi, Boris
Wydane w J Immunother Cancer (2020)

The HGF/c-MET pathway is a driver and biomarker of VEGFR-inhibitor resistance and vascular remodeling in non-small cell lung cancer

od Cascone, Tina, Xu, Li, Lin, Heather Y., Liu, Wenbin, Tran, Hai T., Liu, Yuan, Howells, Kathryn, Haddad, Vincent, Hanrahan, Emer, Nilsson, Monique B., Cortez, Maria A., Giri, Uma, Kadara, Humam, Saigal, Babita, Park, Yun-Yong, Peng, Weiyi, Lee, Ju-Seog, Ryan, Anderson J., Jüergensmeier, Juliane M., Herbst, Roy S., Wang, Jing, Langley, Robert R., Wistuba, Ignacio I., Lee, Jack J., Heymach, John V.
Wydane w Clin Cancer Res (2017)